Evidence map›Paper›PMID 35399999›Full record

ReviewCancer diagnosis & prognosis

Impact of Ubiquitination Signaling Pathway Modifications on Oral Carcinoma.

Efthimios Kyrodimos, Aristeidis Chrysovergis, Nicholas Mastronikolis, Evangelos Tsiambas, Loukas Manaios, Dimitrios Roukas, Pavlos Pantos, Vasileios Ragos, Dimitrios Peschos, Vasileios Papanikolaou

Open access · greenAbstract readReview
In one paragraph

Review in Cancer diagnosis & prognosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Efthimios Kyrodimos1st ENT Department, Hippocration Hospital, National and Kapodistrian University, Athens, Greece.
Aristeidis Chrysovergis1st ENT Department, Hippocration Hospital, National and Kapodistrian University, Athens, Greece.
Nicholas MastronikolisENT Department, Medical School, University of Patras, Patras, Greece.
Evangelos TsiambasDepartment of Cytology, Molecular Unit, 417 Veterans Army Hospital (NIMTS), Athens, Greece.
Loukas ManaiosDepartment of Surgery, "BIOCLINIC'', Athens, Greece.
Dimitrios RoukasDepartment of Psychiatry, 417 Veterans Army Hospital (NIMTS), Athens, Greece.
Pavlos Pantos1st ENT Department, Hippocration Hospital, National and Kapodistrian University, Athens, Greece.
Vasileios RagosDepartment of Maxillofacial, Medical School, University of Ioannina, Ioannina, Greece.
Dimitrios PeschosDepartment of Physiology, Medical School, University of Ioannina, Ioannina, Greece.
Vasileios Papanikolaou1st ENT Department, Hippocration Hospital, National and Kapodistrian University, Athens, Greece.
Hippocration General Hospital · GRUniversity of Ioannina · GRNIMTS Hospital · GRUniversity of Patras · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among intra-cellular homeostasis mechanisms, ubiquitination plays a critical role in protein metabolism regulation by degrading proteins via activating a broad spectrum of ubiquitin chains. In fact, ubiquitination and sumoylation signaling pathways are characterized by increased complexity regarding the molecules and their interactions. The Ubiquitin-Proteasome System (Ub-PS) recognizes and targets a broad spectrum of protein substrates. Ubiquitin conjugation modifies each substrate protein determining its biochemical fate (degradation). A major functional activity of Ub-PS is autophagy mechanism regulation. Interestingly, Ub-PS promotes all stages of bulk autophagy (initiation, execution, and termination). Autophagy is a crucial catabolic process that provides protein degradation and for this reason the interaction with Ub-PS is crucial. Furthermore, ubiquitination controls and regulates specific types of protein targets. Ub-PS is also involved in oxidative cellular stress and DNA damage response. Additionally, the functional role of Ub-PS in ribosome machinery regulation seems to be crucial. Concerning carcinogenesis, Ub-PS is involved in malignant disease development and progression by negatively affecting the corresponding TGF-B-, MEEK/MAPK/ERK-JNK- dependent signaling pathways. In the current review article, we describe the role of Ub-PS biochemical modifications and alterations in oral squamous cell carcinoma (OSCC).

Indexed as

carcinomaoralpathophysiologyprotein degradationreviewUbiquitination

Identifiers

PMID35399999
PMCPMC8962841
OpenAlexW4205262307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.